Chemical industry – Page 108
-
Business
EPA proposes new rules for five chemicals
The US Environmental Protection Agency has proposed new rules that would force companies to report any new use
-
Business
AbbVie emerges from Abbott split
US healthcare giant Abbott has renamed the branded drugs part of its business
-
Business
GSK to build £350m factory in UK
GlaxoSmithKline (GSK) has announced £350 million plans to build its first new UK production plant for almost 40 years in Ulverston, Cumbria
-
News
GSK to build £350 million factory in UK
Tax breaks in the UK budget have prompted GSK to reaffirm its commitment
-
News
India green lights production of patented cancer drug
For the first time India has invoked a ‘compulsory licence’ clause to cut the cost of a patented anti-cancer drug
-
Business
Children's lungs are more susceptible to nanoparticles
Infant lungs are particularly prone to nanoparticle deposition, be it from pollution or inhaled medicines
-
Business
Irish government plans to pick winners in research
Science funding will be targeted to areas that will deliver the biggest return on investment
-
Careers
To ECHA his own
The EU’s Reach regulation involves a huge data gathering operation - Kaihsu Tai is working right at its heart
-
BusinessNanocellulose has paper potential
Material would cut the carbon footprint of paper substantially – by 15% or more, the researchers say
-
BusinessMapping the reactivity of single nanocatalysts
The catalytic behaviour of gold nanorods varies across their surface in unexpected ways
-
FeatureRising from the ashes
Neil Sinclair reports on some exciting new ventures emerging from redundant chemical and pharmaceutical plants
-
OpinionThe elements of drug design
Drug discovery requires experimentation, says Derek Lowe. But chemists can be reluctant to stray from the elements they know and love
-
Business
Business roundup: March 2012
Pharmaceutical Collaboration for neglected tropical diseases A group of 13 pharma companies, three national governments and several global health organisations has come together to target 10 neglected tropical diseases (NTDs) with $785 million (?497 million) in R&D funding. The group aims to ’accelerate progress toward eliminating or controlling [this set ...
-
Opinion
The language of the lab
Derek Lowe wonders what the lab lingua franca might be in the years to come
-
Business
Business roundup: February 2012
Pharmaceutical BMS spends $2.5 billion on antiviral firm Pharma giant Bristol-Myers Squibb (BMS) has struck a deal to buy US biotech Inhibitex for $2.5 billion (?1.6 billion). The move will stock BMS’s pipeline with antivirals, most notably INX-189, a nucleotide polymerase inhibitor which is in Phase II trials for treating ...
-
Opinion
Rewards of repurposing
Derek Lowe discusses how companies are increasingly trying to do more with the compounds they already know a lot about
-
Business
Business roundup: January 2012
Pharmaceutical Mental health drug use up More than one fifth of adults in the US took a mental health drug of some kind in 2010, according to a new report. The authors from Medco Health Solutions, a US pharmacy services company, found that use was higher for women than for ...
-
-
Business
Business roundup: December 2011
Almac to hire 500 over next 12 months UK contract research organisation (CRO) Almac says that it expects to hire about 500 people in the next 12 months, split between its headquarters in Craigavon, Northern Ireland, and its new US site in Souderton, Pennsylvania. Almac, a privately owned company, is ...
-
Opinion
Compounds in the dark
Derek Lowe discusses the compounds you can buy but won't see anywhere in the literature